To date, potential predictive molecular markers for pancreatic cancer have been extensively investigated and some are identified to be significantly correlated with clinicopathologic characteristics and survival,[25] but there is little information on the prognostic value of GRO-α. Here, CXCL1 is linked to pancreatic neoplasm.